Therapies to Slow or Reverse Chronic Kidney Disease Progression

First-Line Therapies

• The American College of Physicians recommends ACE inhibitors or ARBs as first-line therapy for both diabetic and non-diabetic adults with CKD and urine albumin excretion >300 mg/24 hours 2, 3
• RAAS inhibitors have consistently shown effectiveness in slowing progression of both diabetic and non-diabetic nephropathy by reducing proteinuria 3

Blood Pressure Management

• The American Heart Association recommends maintaining BP ≤140/90 mmHg for CKD patients with urine albumin excretion <30 mg/24 hours, and BP ≤130/80 mmHg for those with urine albumin excretion ≥30 mg/24 hours 2, 3
• Blood pressure control is critical in preventing CKD progression, breaking the vicious cycle between hypertension and CKD 3

Lifestyle and Nutritional Interventions

• A Mediterranean-style diet is recommended to reduce cardiovascular risk in CKD patients 4
• Reduced sodium intake to <2 g per day helps control blood pressure and slows progression 3

Metabolic Management

• Lipid management with statin therapy is recommended for adults ≥50 years with CKD 4

Preventive Strategies

• All CKD patients should be considered at increased risk of acute kidney injury, which can accelerate CKD progression 3
• Regular monitoring of kidney function and albuminuria is essential to track disease progression and treatment response 5

Important Caveats

• A comprehensive approach combining multiple interventions yields the best outcomes 5, 1
• The degree of proteinuria reduction correlates directly with kidney protection and reduced cardiovascular risk 6
• Treatment must be individualized based on CKD stage, albuminuria level, comorbidities, and underlying cause 1